A groundbreaking UK study has validated Sleepio, a digital self-help program for insomnia, proving it more effective than conventional face-to-face therapy. Conducted on thousands of participants, the results are compelling and evidence-based.
Insomnia is a complex condition blending psychological and neurobiological factors, as noted by Inserm. It affects 15-20% of French adults, with nearly half experiencing severe symptoms. Traditionally, patients turn to sleep therapists, but innovative digital solutions are emerging to bridge access gaps.
Featured in The Guardian on July 30, 2020, Sleepio—developed by Big Health—is a six-week online program offering a practical alternative to in-person sessions.
Led by the Oxford University Health Sciences Network, the study involved 7,078 insomnia sufferers. Participants using Sleepio gained approximately six extra hours of sleep per week, alongside reductions in anxiety, depression, medication use, and work absences.
"The study showed that, on average, patients using the Sleepio online treatment slept 35.3 hours per week before starting to use it, compared to an average of 41.2 hours per week after," said Tracey Marriott, Director of Clinical Innovation at Oxford University Network.
Researchers found Sleepio superior to standard UK healthcare therapies, with a 56% success rate versus 50%. Four in five participants recommended it, while 70% reported less anxiety and 72% less depression post-treatment. It also led to a 56% drop in prescriptions and 21% fewer sick days.
With high demand overwhelming sleep specialists in the UK—coupled with costly consultations—Sleepio offers accessible, effective relief for the future.
